Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Tadalafil and Finasteride may help treat aggressive melanoma.

Oral minipulse therapy with betamethasone effectively promotes hair regrowth in alopecia areata with fewer side effects.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib is an effective and safe treatment for alopecia areata.

Testosterone metabolites may help relieve diabetic nerve pain.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Finasteride reduces some inflammation in BPH but not all.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Terazosin hydrochloride helps with BPH and blood pressure, but not more than the control.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Apremilast showed mixed results for treating severe alopecia areata.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Dutasteride reduces DHT more effectively than finasteride.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.